Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation

PURPOSE: Cetuximab and panitumumab have an effective therapeutic response in a subset of RAS Wild-Type (WT) metastatic colorectal cancers (mCRCs). Despite molecular-driven selection, all patients do not respond to epidermal growth factor receptor (EGFR) inhibitors and the onset of secondary resistan...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Napolitano, Stefania, Martini, Giulia, Martinelli, Erika, Belli, Valentina, Parascandolo, Alessia, Laukkanen, Mikko O., Sforza, Vincenzo, Morgillo, Floriana, Ciardiello, Davide, Ciardiello, Fortunato, Troiani, Teresa
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2017
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620195/
https://ncbi.nlm.nih.gov/pubmed/28978055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18749
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items